Clostridium difficile: assessing the risks to Australia of an emerging healthcare-related pathogen

艰难梭菌：评估一种新兴的医疗保健相关病原体对澳大利亚的风险

• 批准号: nhmrc : 1006243
• 负责人: Prof Archie Clements
• 金额: $ 78.7万
• 依托单位: Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/clostridium-difficile-assessing-related-pathogen/109159
• 关键词: Clostridium; difficile; assessing; risks; Australia

Clostridium difficile is a bacterium that causes inflammation of the large bowel that can lead to surgical removal of the bowel or death. In North America and Europe, an international epidemic strain has caused large outbreaks of severe, fatal disease. In 2009, this strain was identified for the first time in Perth, Australia. We will investigate strains currently present in Brisbane and Perth and risk of outbreaks occurring from imported and local strains.

艰难梭菌是一种引起大肠炎症的细菌，可导致肠道切除手术或死亡。在北美和欧洲，一种国际流行毒株导致了严重致命疾病的大规模爆发。 2009年，该菌株首次在澳大利亚珀斯被发现。我们将调查布里斯班和珀斯目前存在的菌株以及进口和本地菌株爆发的风险。